Ester Gallo
Overview
Explore the profile of Ester Gallo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Randone P, Sanna E, Dolla C, Gallo E, Mingozzi S, Tarragoni R, et al.
Am J Transplant
. 2024 Jul;
24(10):1896-1900.
PMID: 39029875
The recurrence of primary focal segmental glomerulosclerosis (FSGS) after kidney transplantation is associated with a high graft loss rate with standard treatments based on plasmapheresis with/without rituximab. We present 2...
2.
Allesina A, Lavacca A, Fop F, Giraudi R, Giovinazzo G, Deaglio S, et al.
Clin Transplant
. 2024 Jul;
38(7):e15394.
PMID: 39001595
Introduction: Broad national or international programs contribute to mitigating the expected longer waiting list (WL) time for sensitized patients but with minor benefits for highly sensitized subjects. Therefore, strategies to...
3.
Tarragoni R, Congiu G, Mella A, Augelli G, Fop F, Dolla C, et al.
Front Med (Lausanne)
. 2024 May;
11:1342992.
PMID: 38808134
Background: Acute graft pyelonephritis (AGPN) is a relatively common complication in kidney transplants (KTs); however, the effects on allograft function, diagnostic criteria, and risk factors are not well established. Methods:...
4.
Mella A, Lavacca A, Dodoi D, Presta R, Fop F, Campagna M, et al.
Transplant Direct
. 2024 May;
10(6):e1638.
PMID: 38769985
Background: Transplant glomerulopathy (TG) is the hallmark of chronic antibody-mediated rejection but often occurs without anti-HLA donor-specific antibodies (DSAs) in the assumption that other DSAs may be the effectors of...
5.
Zizzi C, Dolla C, Fop F, Mella A, Sandrone M, Ghigo E, et al.
Kidney Int Rep
. 2024 Mar;
9(3):707-711.
PMID: 38481492
No abstract available.
6.
Diena D, Allesina A, Fop F, Mella A, Cavallo R, Costa C, et al.
Microorganisms
. 2023 Feb;
11(2).
PMID: 36838423
Objectives: To explore the Cytomegalovirus (CMV) burden on the long-term post-transplant course in different donor ages, we evaluated the incidence and risk factors for CMV in our kidney-transplanted patients (KTs)...
7.
Mella A, Mariano F, Dolla C, Gallo E, Manzione A, Di Vico M, et al.
Biomedicines
. 2022 Mar;
10(3).
PMID: 35327510
Kidney transplanted patients are a unique population with intrinsic susceptibility to viral and bacterial infections, mainly (but not exclusively) due to continuous immunosuppression. In this setting, infectious episodes remain among...
8.
Gallo E, Mingozzi S, Mella A, Fop F, Presta R, Burdese M, et al.
BMC Nephrol
. 2021 Nov;
22(1):386.
PMID: 34789191
Background: Rare diseases (RDs) encompass many difficult-to-treat conditions with different characteristics often associated with end-stage renal disease (ESRD). However, data about transplant outcomes in adult patients are still lacking and...
9.
Clari R, Tarella C, Giraudi R, Torazza M, Gallo E, Lavacca A, et al.
Clin Kidney J
. 2021 Feb;
14(1):317-324.
PMID: 33564434
Background: Management of patients with oncohaematological disorders such as monoclonal gammopathy of undetermined significance (MGUS) is a frequent problem in pre-transplant work-up. Insights on disease progression and long-term functional outcomes...
10.
Dolla C, Naso E, Mella A, Allesina A, Giraudi R, Torazza M, et al.
Sci Rep
. 2020 Dec;
10(1):22000.
PMID: 33319849
Despite type 2 diabetes mellitus (T2D) is commonly considered a detrimental factor in dialysis, its clear effect on morbidity and mortality on waitlisted patients for kidney transplant (KT) has never...